|
Clinical outcomes at 1-year and 3-year follow-up between DES group and BMS group |
|||||||||
| Events |
1-year follow-up |
3-year follow-up |
Between 1-year and 3-year follow-up |
||||||
|
|
|||||||||
| BMS group (N = 150 Pts) |
DES group (N = 85 Pts) |
P |
BMS group (N = 150 Pts) |
DES group (N = 85 Pts) |
P |
BMS group (N = 150 Pts) |
DES group (N = 85 Pts) |
P |
|
|
|
|||||||||
| Re-MI (%) |
0 |
1.2 |
0.36 |
0 |
2.4 |
0.06 |
0 |
1.2 |
0.36 |
| Cardiac death (%) |
1.3 |
2.4 |
0.62 |
2.0 |
3.5 |
0.48 |
0.7 |
1.2 |
1.00 |
| TLR (%) |
4.7 |
4.7 |
1.00 |
6.0 |
5.9 |
0.97 |
1.3 |
1.2 |
1.00 |
| MACE (%) |
6.0 |
7.1 |
0.75 |
8.7 |
10.6 |
0.63 |
2.7 |
3.5 |
0.71 |
|
Note: Pts, patients; Re-MI, recurrent myocardial infarction; TLR, target lesion revascularization; MACE, major adverse cardiac events. | |||||||||
Yang et al. Journal of Translational Medicine 2008 6:42 doi:10.1186/1479-5876-6-42 |
|||||||||